Paneldiskusjon om "The Health Impact Fund" 10. mai
Hvordan gjøre nye legemidler tilgjengelig for alle? "The Health Impact Fund" er en ny måte å stimulere til utvikling av legemidler til behandling av sykdommer som rammer fattige. Paneldiskusjonen finner sted i Litteraturhuset i Oslo 10. mai kl. 18.00.
Welcome to the panel discussion: The 'Health Impact Fund' as a Model fora Sustainable Global Order
Time and place: May 10, 2010 06:00 PM, Litteraturhuset, Oslo, Amalie Skram
The event will provide a forum for high-ranking current and former Government officials from the Nordic countries to discuss a concrete proposal for improving access to important medicines especially for poor people. Through this straightforward mechanism, the HIF would give pharmaceutical innovators the option to register any product that would then be sold worldwide at manufacturing cost and be rewarded on the basis of its health impact. The HIF would provide access to new medicines that would otherwise be greatly marked up, stimulate innovators to promote the optimal use of their registered products, and incentivize the development of new medicines for heretofore neglected diseases.
HIF has been launched in Oslo in 2008 (through CSMN at University of Oslo). The purpose of the panel discussion is to remind of the HIF proposal and to provide participants with an up-to-date account of our work on detailing its design and winning stakeholder feed-back and support.
Panel members:
* Sophie Bloemen (HAI /Health Action International, Netherlands)
* Godelieve van Heteren (Director of Europa Arena, Netherlands)
* Thomas Pogge (Yale University/CSMN)
* Goran Tomson (Karolinska institutet, University of Stockholm)
* Sigrun Møgedal (Chair) (WHO, Chair of the Board for the Global
Health Workforce Alliance, the Norwegian HIV/AIDS Ambassador)
More info on The Health Impact Fund:
http://www.yale.edu/macmillan/igh/CSMN:
http://www.csmn.uio.no/Organizer
Thomas Pogge
Free entrance